- Stocks
- Healthcare
- NASDAQ: INVA

Price (delayed)

$13.36

Market cap

$1.35B

P/E Ratio

5.34

Dividend/share

N/A

EPS

$2.5

Enterprise value

$1.46B

The equity has surged by 67% year-on-year and by 18% since the previous quarter

The stock's price to earnings (P/E) is 48% less than its 5-year quarterly average of 10.2

Innoviva's quick ratio has soared by 75% from the previous quarter but it has decreased by 41% YoY

The debt has grown by 2.3% YoY

What are the main financial stats of INVA

Market
Valuations
Earnings

Shares outstanding

101.41M

Market cap

$1.35B

Enterprise value

$1.46B

Price to earnings (P/E)

5.34

Price to book (P/B)

2.14

Price to sales (P/S)

3.94

EV/EBIT

4.35

EV/EBITDA

4.17

EV/Sales

4.25

Revenue

$343.63M

EBIT

$335.83M

EBITDA

$349.67M

Free cash flow

$323.74M

Per share
Balance sheet
Liquidity

EPS

$2.5

Free cash flow per share

$3.19

Book value per share

$6.26

Revenue per share

$3.39

TBVPS

$10.74

Total assets

$1.09B

Total liabilities

$391.61M

Debt

$387.73M

Equity

$634.46M

Working capital

$369.13M

Debt to equity

0.61

Current ratio

98.04

Quick ratio

97.76

Net debt/EBITDA

0.3

Margins
Efficiency
Dividend

EBITDA margin

101.8%

Gross margin

100%

Net margin

73.7%

Operating margin

94.4%

Return on assets

26%

Return on equity

47.8%

Return on invested capital

33.7%

Return on capital employed

31%

Return on sales

97.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Innoviva stock price performed over time

Intraday

-0.37%

1 week

2.3%

1 month

0.83%

1 year

-1.55%

YTD

7.83%

QTD

-0.37%

How have Innoviva's revenue and profit performed over time

Revenue

$343.63M

Gross profit

$343.63M

Operating income

$324.49M

Net income

$253.09M

Gross margin

100%

Net margin

73.7%

INVA's net income is up by 34% year-on-year and by 13% since the previous quarter

The revenue has grown by 21% YoY and by 2% from the previous quarter

The gross profit is up by 21% YoY and by 2% from the previous quarter

INVA's operating income is up by 20% YoY

What is Innoviva's growth rate over time

What is Innoviva stock price valuation

P/E

5.34

P/B

2.14

P/S

3.94

EV/EBIT

4.35

EV/EBITDA

4.17

EV/Sales

4.25

The stock's price to earnings (P/E) is 48% less than its 5-year quarterly average of 10.2

The company's EPS rose by 34% YoY and by 13% QoQ

The equity has surged by 67% year-on-year and by 18% since the previous quarter

The P/B is 11% below the last 4 quarters average of 2.4

The P/S is 36% lower than the 5-year quarterly average of 6.2 but 3.7% higher than the last 4 quarters average of 3.8

The revenue has grown by 21% YoY and by 2% from the previous quarter

How efficient is Innoviva business performance

INVA's return on equity is down by 25% year-on-year

The return on invested capital is up by 12% year-on-year

The company's return on sales rose by 9% QoQ and by 8% YoY

INVA's ROA is up by 4% from the previous quarter but it is down by 2.6% YoY

What is INVA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for INVA.

How did Innoviva financials performed over time

The total assets is 178% greater than the total liabilities

Innoviva's quick ratio has soared by 75% from the previous quarter but it has decreased by 41% YoY

The company's current ratio has surged by 75% QoQ but it fell by 41% YoY

The debt is 39% less than the equity

The equity has surged by 67% year-on-year and by 18% since the previous quarter

The debt to equity has declined by 39% year-on-year and by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.